121 related articles for article (PubMed ID: 2531362)
1. In-vitro lysis of sensitized Trypanosoma cruzi by platelets: role of C3b receptors.
Umekita LF; Mota I
Parasite Immunol; 1989 Sep; 11(5):561-6. PubMed ID: 2531362
[TBL] [Abstract][Full Text] [Related]
2. The effect of C3 depletion on the clearance of Trypanosoma cruzi induced by IgG antibodies.
Mota I; Umekita LF
Immunol Lett; 1989 Jun; 21(3):223-5. PubMed ID: 2504665
[TBL] [Abstract][Full Text] [Related]
3. Lytic rabbit IgG for tissue culture trypomastigotes of Trypanosoma cruzi alters the extent and form of complement deposition.
Rimoldi MT; Tartanian A; Joiner KA
Exp Parasitol; 1989 Feb; 68(2):160-7. PubMed ID: 2647504
[TBL] [Abstract][Full Text] [Related]
4. Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade.
Krettli AU; Pontes de Carvalho LC
Clin Exp Immunol; 1985 Nov; 62(2):270-7. PubMed ID: 3910312
[TBL] [Abstract][Full Text] [Related]
5. The possible mechanism of action of IgG antibodies and platelets protecting against Trypanosoma cruzi infection.
Takehara HA; Mota I
Braz J Med Biol Res; 1991; 24(8):759-65. PubMed ID: 1797263
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody.
Schenkman S; Güther ML; Yoshida N
J Immunol; 1986 Sep; 137(5):1623-8. PubMed ID: 2943798
[TBL] [Abstract][Full Text] [Related]
7. Role of platelets and complement in the clearance of epimastigote forms of Trypanosoma cruzi.
Umekita LF; Piazza RM; Mota I
Braz J Med Biol Res; 1994 Oct; 27(10):2391-9. PubMed ID: 7640629
[TBL] [Abstract][Full Text] [Related]
8. Role of platelets in the in vivo removal of T. cruzi from circulation.
Umekita LF; Mota I
Braz J Med Biol Res; 1990; 23(6-7):593-6. PubMed ID: 2101079
[TBL] [Abstract][Full Text] [Related]
9. Role of the antibody Fc in the immune clearance of Trypanosoma cruzi.
Umekita LF; Takehara HA; Mota I
Immunol Lett; 1988 Jan; 17(1):85-9. PubMed ID: 3127336
[TBL] [Abstract][Full Text] [Related]
10. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement.
Tomlinson S; Pontes de Carvalho LC; Vandekerckhove F; Nussenzweig V
J Immunol; 1994 Oct; 153(7):3141-7. PubMed ID: 8089492
[TBL] [Abstract][Full Text] [Related]
11. Relative resistance of Brazil strain trypomastigote forms of Trypanosoma cruzi to in vitro antibody-dependent complement-mediated lysis.
Murfin DJ; Kuhn RE
J Parasitol; 1988 Dec; 74(6):1046-50. PubMed ID: 3057163
[TBL] [Abstract][Full Text] [Related]
12. Binding of complement to trypomastigotes of a Brazil strain of Trypanosoma cruzi: evidence for heterogeneity within the strain.
Jacobson KC; Washburn RG; Kuhn RE
J Parasitol; 1992 Aug; 78(4):697-704. PubMed ID: 1635029
[TBL] [Abstract][Full Text] [Related]
13. C3 modified at the thiolester site: acquisition of reactivity with cellular C3b receptors.
Schreiber RD; Pangburn MK; Müller-Eberhard HJ
Biosci Rep; 1981 Nov; 1(11):873-80. PubMed ID: 6458338
[TBL] [Abstract][Full Text] [Related]
14. Specificity and role of anti-Trypanosoma cruzi clearance antibodies.
Umekita LF; Barbaro KC; Mota I
Braz J Med Biol Res; 1996 Jan; 29(1):25-31. PubMed ID: 8731328
[TBL] [Abstract][Full Text] [Related]
15. Ligand-binding renders the 160 kDa Trypanosoma cruzi complement regulatory protein susceptible to proteolytic cleavage.
Norris KA
Microb Pathog; 1996 Oct; 21(4):235-48. PubMed ID: 8905613
[TBL] [Abstract][Full Text] [Related]
16. Biological activity of chronic phase antibodies eluted from sensitized Trypanosoma cruzi trypomastigotes.
Umekita LF; Ramos DP; Barbaro KC; Mota I
Immunol Lett; 1999 Nov; 70(2):73-6. PubMed ID: 10569694
[TBL] [Abstract][Full Text] [Related]
17. Agglutination of Trypanosoma cruzi in infected cells treated with serum from chronically infected mice.
Wendelken JL; Rowland EC
J Parasitol; 2009 Apr; 95(2):337-44. PubMed ID: 18922039
[TBL] [Abstract][Full Text] [Related]
18. Specific antibodies induce apoptosis in Trypanosoma cruzi epimastigotes.
Fernández-Presas AM; Tato P; Becker I; Solano S; Copitin N; Berzunza M; Willms K; Hernández J; Molinari JL
Parasitol Res; 2010 May; 106(6):1327-37. PubMed ID: 20237802
[TBL] [Abstract][Full Text] [Related]
19. Binding of antibody and resistance to lysis of trypomastigotes of Trypanosoma cruzi.
Jacobson KC; Fletcher RC; Kuhn RE
Parasite Immunol; 1992 Jan; 14(1):1-12. PubMed ID: 1557225
[TBL] [Abstract][Full Text] [Related]
20. Non-lytic antibodies in H-2-controlled resistance to acute infection with Trypanosoma cruzi.
Juri MA; Ferreira A; Ramos A; Hoecker G
Braz J Med Biol Res; 1990; 23(8):685-95. PubMed ID: 2129269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
